tiprankstipranks
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market
2181
Mabpharm Limited
RESEARCH TOOLSreports
Want to see HK:2181 full AI Analyst Report?

Mabpharm Limited (2181) Income Statement

0 Followers

Mabpharm Limited Income Statement

Last quarter (Q4 2025), Mabpharm Limited's total revenue was ¥365.71M, an increase of 747.70% from the same quarter last year. In Q4, Mabpharm Limited's net income was ¥53.33M. See Mabpharm Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 629.37M¥ 258.23M¥ 87.16M¥ 55.92M¥ 82.88M
Gross Profit
¥ 521.55M¥ 219.39M¥ 75.24M¥ 40.54M¥ 66.11M
Operating Expenses
¥ 516.87M¥ 339.07M¥ 277.22M¥ 266.79M¥ 363.63M
Depreciation and Amortization
¥ 58.23M¥ 51.86M¥ 60.70M¥ 51.55M¥ 43.88M
EBITDA
¥ 62.91M¥ -67.81M¥ -139.08M¥ -152.08M¥ -245.46M
Operating Income
¥ 4.68M¥ -119.67M¥ -201.98M¥ -226.25M¥ -297.52M
Other Income/Expenses
¥ -626.36K¥ -8.28M¥ -7.37M¥ 15.43M¥ 5.78M
Pretax Income
¥ 4.05M¥ -127.95M¥ -209.36M¥ -210.82M¥ -291.74M
Net Income
¥ 55.65M¥ -127.95M¥ -209.36M¥ -210.62M¥ -291.74M
Per Share Metrics
Basic EPS
¥ 0.01¥ -0.03¥ -0.05¥ -0.05¥ -0.07
Diluted EPS
¥ 0.01¥ -0.03¥ -0.05¥ -0.05¥ -0.07
Weighted Average Shares Outstanding
 4.12B 4.12B 4.12B 4.12B 4.12B
Weighted Average Shares Outstanding (Diluted)
 4.12B 4.12B 4.12B 4.12B 4.12B
Currency in CNY

Mabpharm Limited Earnings and Revenue History